Keyword: Erlotinib Hydrochloride , Carcinoma, Non-Small-Cell Lung , Drug Administration Schedule , Skin Manifestations , Lung Diseases, Interstitial , Medication Therapy Management , Molecular Targeted Therapy , Gefitinib pp.16-18
Published Date 2011/1/20
DOI https://doi.org/10.15106/J03022.2011105446

©Nankodo Co., Ltd., 2011

基本情報

電子版ISSN 2432-8723 印刷版ISSN 1342-0569 南江堂

関連文献

もっと見る

文献を共有